Clinical Trials Browser

Phase 2 × Diffuse Intrinsic Pontine Glioma × Erlotinib Hydrochloride × Clear all

NCT01182350 2019-09-04

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Phase 2 Terminated

53 enrolled 12 charts

Diffuse Intrinsic Pontine Glioma

NCT02233049 2018-07-23

BIOMEDE

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma